UroGen Pharma URGN Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about UroGen Pharma's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is UroGen Pharma's operating lease liabilities (current)?
- UroGen Pharma (URGN) reported operating lease liabilities (current) of $589K in Q1 2026.
- How has UroGen Pharma's operating lease liabilities (current) changed year-over-year?
- UroGen Pharma's operating lease liabilities (current) decreased by 7.1% year-over-year, from $634K to $589K.
- What is the long-term trend for UroGen Pharma's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), UroGen Pharma's operating lease liabilities (current) has grown at a -16.7% compound annual growth rate (CAGR), from $1.2M to $481K.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.